Success Rate and Utility of Ultrasound-guided Synovial Biopsies in Clinical Practice by Najm, A. et al.
This is an author produced version of Success Rate and Utility of Ultrasound-guided 
Synovial Biopsies in Clinical Practice.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/106542/
Article:
Najm, A., Orr, C., Heymann, M.F. et al. (3 more authors) (2016) Success Rate and Utility of
Ultrasound-guided Synovial Biopsies in Clinical Practice. Journal of Rheumatology. ISSN 
0315-162X 
https://doi.org/10.3899/jrheum.151441
promoting access to
White Rose research papers
eprints@whiterose.ac.uk
http://eprints.whiterose.ac.uk/
F
o
r P
eer R
eview
!
!
!
!
!
!
Success rate and utility of ultrasound guided synovial 
biopsies in clinical practice. 
!
!
Journal: The Journal of Rheumatology 
Manuscript ID 2015-1441.R1 
Manuscript Type: Manuscript 
Date Submitted by the Author: 29-Apr-2016 
Complete List of Authors: Najm, Aurélie; Centre Hospitalier Universitaire de Nantes, Rheumatology 
Orr, Carl; St.Vincent\'s University Hospital , Rheumatology 
Heymann, Marie Françoise; Centre Hospitalier Universitaire de Nantes, 
Pathology 
Bart, Géraldine; Centre Hospitalier Universitaire de Nantes, Rheumatology 
Veale, Douglas; St.Vincent's University Hospital , Rheumatology 
Le Goff, Benoit; Hôtel-Dieu, Rheumatology;   
Keywords: Biopsy, Ultrasonography, Synovium, Synovitis, Arthritis 
!!
!
!
F
o
r P
eer R
eview
1 
 
Success rate and utility of ultrasound guided synovial biopsies in clinical 
practice. 
Aurélie Najm
1
, Carl Orr
2
, Marie-Françoise Heymann
3
, Géraldine Bart
1
,Douglas J Veale
2
, 
Benoît Le Goff
1
. 
1. Department of Rheumatology, Hôtel-Dieu Hospital, 1, place Alexis-Ricordeau, 44093 
Nantes cedex 1, France. 
2. University College Dublin Department of Rheumatology, St Vincent’s Hospital, Dublin, 
Ireland 
3. Department of pathology, Hôtel-Dieu Hospital, 1, place Alexis-Ricordeau, 44093 Nantes 
cedex 1, France. 
 
Abstract (249 WORDS) 
The utility of synovial biopsy in increasing our understanding of the pathogenesis of 
inflammatory arthropathies, as well as in evaluating treatments is well established. Ultrasound 
allows synovial assessment and therefore assists in biopsying synovial tissue in a safe and 
well-tolerated manner. 
Objectives: (a) To determine the rate of success in retrieving synovial tissue using ultrasound 
guidance; (b) to describe the indications for US guided synovial biopsies in the clinical 
setting; (c) to determine how frequently the synovial biopsy can lead to a clear diagnosis and 
(d) to assess the quality of the synovial tissue obtained using this technique. 
Methods: Synovial biopsies of small and large joints were performed under ultrasound 
guidance between January 2007 and December 2014 using a semi-automatic core biopsy 
needle. The biopsy procedure was considered successful if synovial tissue was found at 
histological examination. 
Results: Seventy-four patients with undifferentiated arthritis underwent 76 synovial biopsies. 
The success rate in retrieving synovial tissue was 81.6% (62/76). One patient taking salicylic 
acid at 75mg at the time the biopsy presented with hemarthrosis 48 hours after the procedure, 
which resolved following simple arthrocentesis. A definite diagnosis was achieved in 16.1% 
of the patients where synovial tissue was sampled successfully.  
Conclusion: Ultrasound guided synovial biopsies in clinical practice can be performed safely 
on patients with undifferentiated arthritis and with heterogeneous presentations. The rate of 
success in acquiring synovial tissue is high. The procedure usually retrieves quality tissue and 
leads to a definite diagnosis in a significant minority of patients. 
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Introduction 
 
Synovial tissue is the principal target and end organ involved in the pathogenesis of multiple 
articular disease processes (1,2). Synovial tissue analysis has been widely used for basic 
science, translational and clinical research. Moreover, synovial assessment allows for 
studying many aspects of disease processes including pathogenesis (3), the identification of 
relevant targets clinical features (4), diagnosis, prognosis (5) as well as in assisting in 
assessments of response to treatment (6–8). 
 
Histological and immunohistological synovial assessment is also used as a diagnostic tool (9). 
Indeed, it is especially useful for identifying arthritis of an infectious aetiology, when synovial 
fluid or blood analysis (Gram, Ziehl) and cultures are negative or in cases where empiric 
antimicrobial therapy has been commenced before it has been possible to examine the 
synovial fluid (10). The bacterial broad range 16S ribosomal RNA can also be tracked down 
by polymerase chain reaction (PCR) on synovial tissue (11). The same methods allow 
identification of fungal, mycobacterial, spirochetes and Tropheryma Whipplei in the joint. 
False negative for monosodium urate crystals (MSU) and calcium pyrophosphate (PPC) occur 
frequently at microscopic examination of the synovial fluid (12), and synovial tissue 
assessment can be helpful with typical histological features. Finally, synovial benign tumours 
such as primary or secondary osteochondromatosis or villonodular synovitis can be diagnosed 
as well, showing specific macroscopic and histological pattern. 
 
There are several techniques to obtain synovial tissue from the joints. Synovial biopsy was 
performed by Forestier in 1932 using a needle blindly introduced in the knee joint (13). Polley 
(14) and Parker (15) described new smaller diameter needles that have been widely used over 
the past years for knee synovial biopsies. Beaulé (16), Parlier and Cuau (17) then described a 
technique of synovial biopsy under direct visualisation under flurorscopy with a semi-
automatic Tru-cut needle. This technique allows performing multi-sites biopsies such as hips, 
shoulders, elbows, ankles and wrists. Synovial biopsies were later performed under direct 
vision using 2 portals via an arthroscope (18).  Although this technique is usually well 
tolerated (9), it remains invasive, expensive and not yet widely available. Moreover, it has 
been shown that microscopic measurements of synovial inflammation does not differ between 
biopsies taken blindly or under guided vision (19). 
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More recently, ultrasound guided synovial biopsies have been developed. Musculoskeletal 
ultrasound (US) is very commonly used nowadays, especially for guiding interventional 
procedures (20,21). This technique has the benefit of being low cost, rapidly and easily 
performed without the need for exposing the patient to ionising radiation, and is widely 
available (22). It is more practical than arthroscopy for biopsying small joints and allows 
guidance to the thickest synovial zones. Moreover, Kelly et al (23), reported that increasing 
synovial thickness on ultrasound correlated with increasing grades of synovitis on  
histological examination. However, few studies have reported on synovial biopsies performed 
in routine clinical practice (24,25). It is unknown if the success and the quality of the biopsy 
are the same as the one performed in a research setting. Finally, their clinical utility is still a 
matter of debate. 
 
The aims of our study are (a) to describe the indications for US guided synovial biopsies in 
the clinical setting, (b) to determine the rate of success in acquiring synovial tissue using this 
approach and to report the complications, (c) to determine how frequently the synovial biopsy 
can lead to a clear diagnosis and (d) to assess the quality of the synovial tissue obtained using 
this technique. 
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Material and methods 
 
Patients and histological diagnosis 
We included all patients who underwent a US guided synovial biopsy between February 2007 
and December 2014 in Nantes University hospital for arthritis without definite diagnosis 
based on the history, clinical examination or imaging. During this service evaluation study, 
we collected epidemiological (age, sex) and clinical data (clinical presentation, indication, 
biopsied joint, complications) using a standardized form. Final histological diagnosis was 
reported by 3 pathologists who had an expertise in assessing synovial tissue in a formal report 
based on a Hematoxylin and Eosin staining. Patients were followed to determine the clinical 
course of their symptoms. 
 
US guided synovial biopsies 
Synovial biopsies were performed under US guidance using a Philips HD11 XE ultrasound 
machine and a 7-13MHz transducer from Philips Healthcare. They were performed in an 
outpatient and inpatient setting dep nding on the patient’s presentation. All patients 
underwent a thorough assessment of the joint to be biopsied. Vascular and nervous structures 
nearby were identified and synovial thickness was assessed. 
All the biopsy procedures were performed by one operator (BLG) who had an expertise in US 
examination, under sterile technique (wearing gown, sterile gloves, mask and a surgical cap). 
Skin disinfection was processed with a 5 steps protocol using Iodine polyvidone or Hibiscrub 
if the patient had Iodine past history of allergy. The joint was draped and a sterile field thus 
generated. The transducer was covered with sterile gel and sterile sheath. Anaesthesia was 
performed injecting 5 to 10 ml of lidocaine 2% in the subcutaneous tissue and up to the joint 
capsule. If an effusion was present, synovial fluid was withdrawn and sent to the laboratory 
for cell count, crystal microscopy, bacteriological, mycobacteriological and/or fungal analysis 
depending on the patient clinical history and features. A semi-automatic guillotine biopsy 
“Tru-cut®” needle from TEMNOS has been used for all the biopsies. The calibre used was 16 
Gauge (G) for small and intermediate joints or 14G for large joints such as hips, shoulders and 
knees. Coaxial needle was inserted under US guidance through the skin until reaching the 
articular cavity. The coaxial needle was positioned in intimate contact with the synovium. The 
semi-automatic guillotine biopsy “Tru-cut®” needle was then inserted through the cannula of 
the co-axial needle, still under US guidance. Once positioned within the zone of interest of the 
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synovial tissue, the Tru-cut® needle was triggered collecting a piece of synovial tissue 
according to the size of the joint. This Tru-cut® needle was repeatedly inserted through the 
co-axial needle and triggered to obtain the appropriate number of samples. Then, these two 
needles were removed and a classical bandage was applied. Patients were recommended to 
have 48 hours rest after the procedure. 
Depending on the indication of the biopsy and the size of the joint, 3 to 8 biopsies were 
performed per procedure and sent for bacteriological, mycobacteriological and/or fungal 
examination in appropriate laboratories. At least 1 sample was fixed in formalin 4%, 
embedded in paraffin and sent to the pathology laboratory. When the clinical history was 
relevant extra samples were sent for universal bacterial polymerase chain reaction (PCR) 
(ARN 16S), universal fungal PCR (ARN 18S) and Trophyrema Whipplei or Lyme PCR.  
 
Analysis of the quality and quantity of the synovial tissue retrieved during synovial 
biopsies 
All the synovial biopsies were blindly read by one rheumatologist (AN). The number of 
samples per patient, the presence or absence of synovial tissue, the presence or absence of a 
synovial lining layer, the length and the width, the total area of the biopsy (mm2), the area of 
proper synovial tissue (mm2), was assessed in standardized manner with the NDP viewer® 
software. These findings were compared to the histological findings described on the 
pathologist reports which were the gold standard. In case of disagreement between 
rheumatologist and pathologist, an expert reader (DV) was responsible for final decision. We 
considered the biopsy successful when synovial tissue was seen at the histological 
examination. Good quality was defined as: sufficient size (>0,5 mm
2
) (26), preserved tissue 
allowing assessment by pathologists and presence of lining layer. 
 
Statistical analysis 
Mean and median were used to describe quantitative data according to their Gaussian 
distribution. Number and percentage were used to report qualitative data. Fisher test has been 
used to compare percentage. Kappa coefficient calculation was used to assess the 
interobserver reliability for histological analysis. p<0.05 was considered as statistically 
significant. All statistics were made through GraphPad Prism 6.0® software. 
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Results 
Patient characteristics 
Seventy-four patients underwent 76 US guided synovial biopsy procedures. Demographic and 
clinical features of patients included in the study are shown in Table 1. Mean age was 57 
years (Range 13-86 years) and there were 39 (52.7%) men. Most of the patients presented 
with an undifferentiated chronic monoarthritis (54.6%, n=41). The biopsied joints were 
reparsed as followed: 46 knees (60.5%), 6 ankles (8%), 6 wrists (8%), 5 shoulders (7%), 4 
hips (5%), 2 elbows, 2 sternoclavicular joints, 2 metatarso-phalangeal joints and one pubic 
symphysis, one acromio-clavicular joint and one peroneal tenosynovitis. Patients were mainly 
referred to rule out the diagnosis of septic arthritis (82.4%, n=61). 
 
US guided biopsy procedure was safe and successful. 
Overall, 62 of the 76 biopsies (81.6%) yielded synovial tissue according to the pathologists’ 
analysis. Within these 62 biopsies, the main histological finding was a non-specific 
inflammatory mononuclear cell infiltrate (lymphocyte, monocytes and plasma cells) (81%, 
n=50). A mild neutrophil infiltrate was seen in 24 (50%) of these biopsies. 8 (13%) biopsies 
showed specific histological lesions (Figure 1). A major neutrophil cell infiltrate consistent 
with a septic arthritis was found in 2 cases. 2 biopsies showed a synovial infiltration of 
positive Perls’ siderophages (villo-nodular synovitis). 1 biopsy showed vascular and 
interstitial deposits of Sirius red staining protein consistent with amyloidosis AL. 1 biopsy 
contained tophi surrounded by lymphocytes and giant cells. 1 biopsy found dystrophic 
cartilage inside the synovial tissue; consistent with synovial osteochondromatosis. Finally, 1 
biopsy showed an articular localisation of lymphoma. Four biopsies retrieved normal synovial 
tissue without any inflammatory cell infiltrate (Table 2). 
The 14 failed biopsies occurred in both small and large joints. Percentages of failed biopsies 
per joint were as follows: Glenohumeral joints n=3/5 (60%), ankle n=3/6 (50%), hip n=2/4 
(50%), wrist n=2/6 (38.3%), elbow n=1/2 (50%), sternoclavicular joint n=1/2 (50%), knees 
n=2/46 (4.3%). In case of failure, histological analysis showed mainly connective and adipose 
tissue in 10 cases, fibrin and leucocytes in 3 cases, tendon in 1 case. Tolerance per procedure 
was excellent. One patient taking acetyl salicylic acid at the time of the biopsy presented with 
Page 7 of 21
F
o
r P
eer R
eview
8 
 
a haemarthrosis 48 hours after the procedure, which resolved following arthrocentesis within 
one week.  
 
Overall, 10 (16.2%) definitive diagnoses were made based only on synovial tissue histological 
or PCR analysis. 
 
Long term follow-up (mean 34.9 months (Range; <1 month-96 months) and final diagnosis 
were available for 66 of the 74 patients (Table 3). No patient has since been diagnosed with 
an infectious arthritis or villo-nodular synovitis or developed any complication of the biopsy 
procedure. In three of the cases where the diagnosis remained unclear despite the US guided 
biopsy and in two case of failed biopsy, patients underwent secondary procedures. One of 
them had an arthroscopic examination after the US guided biopsy and four of them had an 
open synovectomy. One of those synovectomy allowed a diagnosis of chondrocalcinosis on 
pathological examination. 
 
Quality and quantity of the synovial tissue retrieved after US guided synovial biopsies. 
Finally, the synovial tissue retrieved was assessed for quality and quantity. For this purpose, 
we analysed the histological characteristics per sample retrieved during the procedure (Figure 
2). The median number of sample taken per patient was 1 (IQR 1-3) leading to a total of 125 
samples available for analysis. Mean length and width of the biopsy samples were 6.34 
millimetres (mm) (+/- 3.60) and 1.70 mm (+/- 0.77) respectively. The mean total area of the 
samples was 8.77mm
2
.  
Biopsies showed synovial tissue at the histological examination in 102 samples (80.1%). The 
average area of synovial tissue is these samples was 6.36 mm
2
 corresponding to 72.5% of the 
total area of biopsied tissue. The other type of tissue present on these biopsies were 
connective tissue in 101 cases (80.8%), adipose tissue in 42 cases (33.6%), tendon in 14 cases 
(11.2%) and fibrin in 24 cases (19.2%). The 23 samples retrieving no synovial tissue were 
composed of fibrin in 15 cases (12%), conjunctive and adipose tissue in 17 cases (13.6%), 
tendinous tissue in 3 cases (3.15%), cartilage in 3 cases (3.15%) and muscle in one case 
(0.8%).  
Synovial lining layer was found in 92.6% of the successful biopsies.  
We finally compared our histological final finding regarding presence or absence of synovial 
tissue with the ones given by the pathologist and found 97.1% of agreement. Interobserver 
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reliability for presence/absence of synovial tissue was high with a kappa coefficient of 0.90 
(95% CI = 0.763 to 1). 
 
Discussion  
 
Given the fact that synovial tissue analysis has been mostly used for research purposes, our 
study highlights the potential diagnostic role of synovial biopsy in routine clinical practice. In 
order to develop this technique in clinical practice, the patient needs to be offered a well-
tolerated technique with an acceptable rate of success.  
 
To date, two different techniques of US guided synovial biopsies have been described. Both 
have been shown to be safe, and well tolerated by the patients (22). The first method requires 
a single portal with a flexible or rigid biopsy forceps. The portal is directly introduced inside 
of the joint to perform biopsies (27). The second technique as outlined above, requires an 
empty co-axial needle that is inserted inside of the joint and a semi-automatic guillotine-type 
needle that is inserted through the co-axial. The procedure is not painful after the local 
anaesthesia and once the co-axial needle is settled and this technique allows retrieving several 
biopsies during the same procedure without moving the co-axial needle. To our knowledge, 
five other studies, reporting their experience of US guided synovial biopsies, have been 
published to date. Two reported their experience using the first technique (27,28), one of them 
a technique using semi-automatic guillotine-type needle without co-axial needle (23) and two 
of them using the second technique outlined above (24,25).  
 
The success rates in retrieving synovial tissue described by other authors vary from 89% to 
100% (23,25,27–29). Although, the rate of success in our cohort was slightly lower, for which 
there are several potential reasons. Our patients comprised a heterogeneous group regarding 
clinical features and the joints that have been biopsied among those studies and there were 
also minor differences in techniques in 2 of the studies referenced above. Moreover, no 
biopsies have been done prior 2007 in our centre and 43% of the failures occurred within the 
first 18 months (6 on 14), especially in more challenging joints such as ankles, wrists, hips or 
shoulders. This might correspond to the operator learning curve. However, our success rate 
remains equivalent to the highest rates described for synovial biopsies with blind needle (48 
to 85%) (30).  
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In our study, patients were referred mostly by their GPs or their rheumatologist with no clear 
diagnosis despite multiple punctures with synovial fluid analysis and imaging consisting in 
computed tomography scanner (CT-scan) or magnetic resonance imaging (MRI). Given the 
fact that low-grade infection often evolve in chronic arthritis with joint destruction, it is very 
important to pursue atypical germs such as tuberculosis, fungi, Tropheryma Whipplei, 
Borrelia Burgdorferi. Moreover, some of the more common bacteria can be responsible of   
low-grade infection in some rheumatic patients because of immunosuppression. In all these 
situations, the biopsy allows a quick bacteriological examination with Gram staining, then 
later culture and PCR analysis for atypical organism. Indeed, 2 patients were diagnosed with 
Lyme and articular Whipple disease by PCR analysis. Interestingly, the Whipple PCR that 
was performed on the synovial fluid collected during procedure was negative. There is one 
previously reported similar cases where synovial fluid PCR failed to demonstrate the presence 
of Tropheryma Whipplei but the synovial tissue PCR was positive (31).  
Bacterial culture in both synovial fluid and synovial membrane is a key examination for septic 
arthritis diagnosis. However, using those methods, infectious agents was isolated in only 
41,2% of the patients (38.7 % of synovial fluid and 23.5 % of synovial membrane positive 
cultures) (32).Therefore, histological  synovial cell infiltrate analysis  is also relevant for 
septic arthritis assessment. A neutrophilic cellular infiltrate, has been showed to be highly 
associated with septic arthritis (33). Their presence inside of the synovial tissue is considered 
as a sufficient evidence for the diagnosis of septic arthritis. Regarding the data we present, the 
diagnosis of septic arthritis was established following the histological examination of 2 
patients. Interestingly, after empiric antimicrobial therapy was commenced in these 2 patients, 
no relapse occurred within at least 6 years follow-up for both. This analysis can also be useful 
in fibrocartilagenous joints (acromio-clavicular, pubic symphysis) where fluid is rarely found 
even in case of inflammation. Furthermore, we can conclude from our data, that no patient of 
our cohort has been further diagnosed with infectious arthritis. This technique can therefore 
be considered as reliable to rule out septic arthritis assessment, permitting thus for local 
treatments such as steroids injections. 
 
More rarely, synovial biopsy can be performed for synovial tumour assessment, especially 
villo nodular synovitis or osteochondromatosis. The 2 patients in our cohort diagnosed with 
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villo-nodular synovitis underwent surgical synovectomy. The histological examination of the 
tissue confirmed those findings. 
 
For the biopsy to be useful in clinical practice, the quality of the biopsies retrieved has to be 
good. Quality of a synovial biopsy has been defined for research recently (23). But no 
definition has been given for the clinical setting yet. In our study, we defined good quality as: 
sufficient size defined by synovial tissue area > 0,5mm
2
, preserved tissue allowing assessment 
by pathologists and presence of lining layer. In our cohort, the quality was good enough to 
allow a histological examination in all biopsies retrieving synovial tissue. Lining layer was 
found in 92.2% of the cases. In some instances, the lining layer could be identified but was 
not connected to the main biopsy, which may have occurred during tissue processing or may 
represent separation due to fibrin deposition in case of ulcerative synovitis.   
 
No study has thus far demonstrated a predictive clinical value for histological findings in 
identifying those with early arthritis or those that will go on to have an aggressive disease 
course (6,9,10) . Indeed, multiple studies tried to determine histological cell infiltrates 
patterns matching with different rheumatologic conditions. There is undeniable differences 
between RA and Psoriatic arthritis (34,35), RA and Ankylosing Spondylitis (AS) (36) and RA 
and osteoarthritis (OA) (37,38). OA synovial membrane is known to show less inflammatory 
infiltrate and less vascularity than their inflammatory counterparts (RA, PsA, AS). RA 
synovium has been described to show a higher number of B cells and more rarely ectopic 
follicles, helping in the diagnosis. The high grade synovitis features are more consistent with 
RA (39). However, despite those differences, no algorithm is able to predict the evolution in 
early arthritis (33). 
Given this, the histopathologist was rarely able to determine the type of inflammatory 
arthritis. However, by ruling out or confirming  infectious arthritis or synovial tumour, it is 
clear enough that US guided synovial biopsy is helpful on patients with remaining unknown 
diagnosis despite synovial fluid analysis, X-ray, CT scan and/or MRI examinations. In our 
setting, synovial biopsies allowed to treat some patients by achieving a definite diagnosis, or 
to give systemic immunosuppressive or local therapies such as intraarticular steroid 
injections. We acknowledge that our work has limitations. One limitation is the monocentric 
design of our study. The biopsies were performed by a trained investigator and the 
pathologists in our centre have an expertise in biopsy assessment. This could be a limit for the 
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generalization of those results. Although all patients had 3 to 8 biopsies taken, 55% of them 
had a single fragment sent to pathology department. This might be another limitation. 
 
Finally, one of the main concerns about any procedure is its tolerance. In our cohort, one 
patient treated with salicylic acid presented with knee haemarthrosis 48 hours after the 
procedure. Overall, in our cohort, the adverse effects rate was 1.35% (IC 95 -1.3-4) (1/74) and 
no severe adverse event (life-threatening, leading to patient admission in hospital or with a 
risk of sequelae) occurred. The arthroscopic biopsies have the advantage to be retrieved under 
direct vision and therefore allow a histological analysis of the inflamed areas within the joint. 
However, this procedure is more invasive and has multiple adverse effects (joint infection; 
wound infection; haemarthrosis; deep venous thrombosis; neurological damage, 
thrombophlebitis) (40). 
 
 
 
Conclusion 
Our study highlights the potential diagnostic role of synovial biopsy. To our knowledge, it is 
the first study describing indications, tolerability, rate of success, diagnosis role and quality of 
ultrasound guided synovial biopsy in the clinical setting. Ultrasound guided synovial biopsy is 
performed in clinical practice in a heterogeneous population with variant clinical features. The 
success rate of the procedure remains high with only rare and minor complications. 13.3% 
achieved a definitive diagnosis leading to a specific treatment. In other patients, we could rule 
out the diagnosis of septic arthritis. Therefore, this procedure should not only be used for 
research purposes, but may also be used routinely in undifferentiated arthritis.  
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Legends for illustrations: 
Figure 1 A, B, C, D, E. Synovial biopsies of 5 specific histological lesions. A.Fibrin deposits 
with neutrophils infiltrate (asterix). Septic arthritis. B. Villo nodular synovitis. Hematoxylin 
and Eosin staining.C.Villo nodular synovitis with Perl’s staining showing siderophages 
(arrow head). D. Cell infiltrate within synovial tissue in an articular lymphoma. E. Amyloids 
(cross) revealed by Sirius red staining. AL amyloidosis. F. Micro tophi surrounded by giant 
cells and lymphocytes (black arrow) leading to gout diagnosis. 
 
Figure 2. Example of the sample histological analysis. Black line is the global area 
measurement; red line is the width measurement and white line in the length measurement. 
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Table 1. Demographic and clinical features of the patients. 
 
    No.  (%) 
Gender       
  Female 35 47,3 
  Male 39 52,7 
Mean age, years (Range)   57 (13-86) 
        
Indications        
  Undifferentiated chronic monoarthritis 41 54,7 
  Acute monoarthritis  18 24,0 
  Chronic undifferentiated oligoarthritis  7 9,3 
  Chronic polyarthritis  6 8,0 
  Chronic bursitis 1 1,3 
  Chronic tenosynovitis  1 1,3 
  Acute polyarthritis  1 1,3 
 
No: number. %: percentage 
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Table 2. Histopathological analysis. 
 
1
 2 infectious arthritis (hip, ankle) treated on typical histological aspect with no relapse after 6 
weeks of empiric antibiotics; MTP: metatarsophalangeal. 
 
!
Histopathological findings Number of biopsy 
Normal synovium 4 
Inflamed synovium  50 
Cell infiltrate  
Lymphocytes 50 
Plasma cells 22 
Neutrophils 24 
Specific lesions 8 
Villonodular synovitis (shoulder and knee) 2 
Infectious arthritis 
1
 2 
Amyloid arthritis (knee) 1 
Articular localization of mantle B cell lymphoma 
(ankle) 
1 
Gout (first MTP) 1 
Osteochondromatosis (knee) 1 
Failure 14 
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Table 3. Overall final diagnosis after follow up 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
No: number; %: percentage 
 
!
Final diagnosis No.  (%) 
Rheumatoid arthritis 7 9,5 
Ankylosing spondylitis 2 2,7 
Psoriatic arthritis 5 6,8 
Degenerative arthropathy 12 16,2 
Crystal arthropathy 4 5,4 
Chondrocalcinosis 2 2,7 
Gout 3 4,1 
Villo-nodular synovitis 2 2,7 
Osteochondromatosis 1 1,4 
Giant cell arthritis 1 1,4 
Behcet's disease 1 1,4 
Latent infectious arthritis 4 5,4 
Others 2 2,7 
Undifferentiated arthritis 21 28,4 
Lost to follow-up 7 9,5 
Total 74 100 
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Figure 1 A, B, C, D, E. Synovial biopsies of 5 specific histological lesions. A.Fibrin deposits with neutrophils 
infiltrate (asterix). Septic arthritis. B. Villo nodular synovitis. Hematoxylin and Eosin staining.C.Villo nodular 
synovitis with Perl’s staining showing siderophages (arrow head). D. Cell infiltrate within synovial tissue in 
an articular lymphoma. E. Amyloids (cross) revealed by Sirius red staining. AL amyloidosis. F. Micro tophi 
surrounded by giant cells and lymphocytes (black arrow) leading to gout diagnosis.  
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Figure 2. Example of the sample histological analysis. Black line is the global area measurement; red line is 
the width measurement and white line in the length measurement.  
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